Lapatinib CAS NO.231277-92-2

Min.Order Quantity:: 100 Metric Ton

Purity:: 98%min

Port:: QINGDAO CHINA

Payment Terms:: L/C,T/T,MoneyGram,Other

Add to Inquiry Cart

Product Details

Keywords

231277-92-2
Lapatinib seller in China
Sell high quality 231277-92-2 produced in China factory

Quick Details

ProName: Lapatinib
CasNo: 231277-92-2
Molecular Formula: C29H26ClFN4O4S
Appearance: white powder
Application: Used for research and industrial manuf...
DeliveryTime: Within 3-7 days after receipt of your ...
PackAge: As customer request
Port: QINGDAO CHINA
ProductionCapacity: 100 Metric Ton/Day
Purity: 98%min
Storage: Store in a cool,dry place and keep awa...
Transportation: Common products:Sea/Air/Courier Dange...
LimitNum: 100 Metric Ton

Superiority

triumph chemical title

triumph company office picture

triumph company advantage

triumph testing title picture

triumph testing way

welcome to contact us

lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.

Details

details

specifications
lapatinib
1.cas:231277-92-2
2.purity:99%
3.white powder
4.for breast cancer and other solid tumours
lapatinib
cas-no.:231277-92-2
molecular formula:c29h26clfn4o4s
molecular weight:581.0575432
purity:99%
appearance:white to yellow powder

lapatinib is an orally active drug for breast cancer and other solid tumours. it is a dual tyrosine kinase inhibitor which interrupts the her2 growth receptor pathway. it is used in combination therapy for her2-positive breast cancer. it is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress her2 (erbb2)

specifications
lapatinib
1.cas:231277-92-2
2.purity:99%
3.white powder
4.for breast cancer and other solid tumours
lapatinib
cas-no.:231277-92-2
molecular formula:c29h26clfn4o4s
molecular weight:581.0575432
purity:99%
appearance:white to yellow powder

lapatinib is an orally active drug for breast cancer and other solid tumours. it is a dual tyrosine kinase inhibitor which interrupts the her2 growth receptor pathway. it is used in combination therapy for her2-positive breast cancer. it is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress her2 (erbb2)